High Throughput, Late-Stage Drug Diversification in Neurodegenerative Disease
A family of Oligopyridyl (OP) compounds are presented that are synthetically trivial, scalable, and potent antagonists of relevant aPPIs in the human brain.
G. Jernigan
· 0 citations